 | • レポートコード：QYR2104Z0127 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、進行腎細胞がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、ホルモン療法、治験療法）、用途別市場規模（病院、がん研究所、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・進行腎細胞がん治療の市場動向 ・企業の競争状況、市場シェア ・進行腎細胞がん治療の種類別市場規模（放射線療法、化学療法、ホルモン療法、治験療法） ・進行腎細胞がん治療の用途別市場規模（病院、がん研究所、外来手術センター、その他） ・進行腎細胞がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・進行腎細胞がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・進行腎細胞がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・進行腎細胞がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・進行腎細胞がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Acceleron Pharma、Argos Therapeutics、AVEO Pharmaceuticals、Bayer、Bristol-Myers Squibb Company、Eisai、Exelixi、Genentech、Immatics Biotechnologies、Merck、Novartis、Ono Pharmaceutical、Pfizer、Rexahn Pharmaceuticals、Hoffmann-La Roche） ・結論 |
Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell carcinoma is the most common type of kidney cancer in adults that represents nearly 2-3% of all cancer cases in adults. The disorder is asymptomatic in advanced renal cell carcinoma at initial stages that results with people often in the advanced stages of the disease by the time it is discovered. The initial symptoms of renal cell carcinoma are a general feeling of being unwell, hypertension, flank pain, weight loss, fever, blood in the urine, night sweats, and a mass in the abdomen. Management of renal cell carcinoma has seen significant development in the past few years, and new approaches are being established. Advanced renal cell carcinoma is a disease that normally cannot be treated by general therapy and is challenging to treat. Surgical removal of one or both kidneys should be considered in patients who suffer from metastatic disease before systemic therapy.
Increase in aging population is one of the major factors driving the revenue growth of the renal cell carcinoma market. Furthermore, renal cell carcinoma is a rare disease with a small patient-base constitutingall ages from infants to older adults. However, the disease is predominantly noted in age group of ~ 60-70 years, exposing a higher probability of occurrence. Expanding research into orphan drugs is a factor projected to create lucrative revenue potential for drug makers of renal cell carcinoma.
Market Analysis and Insights: Global Advanced Renal Cell Carcinoma Therapeutics Market
The global Advanced Renal Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Advanced Renal Cell Carcinoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Advanced Renal Cell Carcinoma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Advanced Renal Cell Carcinoma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Advanced Renal Cell Carcinoma Therapeutics market.
Global Advanced Renal Cell Carcinoma Therapeutics Scope and Market Size
Advanced Renal Cell Carcinoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Advanced Renal Cell Carcinoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Radiation Therapy
Chemotherapy
Hormone Therapy
Investigational Therapy
Segment by Application
Hospitals
Cancer Research Institutes
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Acceleron Pharma
Argos Therapeutics
AVEO Pharmaceuticals
Bayer
Bristol-Myers Squibb Company
Eisai
Exelixi
Genentech
Immatics Biotechnologies
Bayer
Bristol-Myers Squibb Company
Ono Pharmaceutical
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiation Therapy
1.2.3 Chemotherapy
1.2.4 Hormone Therapy
1.2.5 Investigational Therapy
1.3 Market by Application
1.3.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Perspective (2016-2027)
2.2 Advanced Renal Cell Carcinoma Therapeutics Growth Trends by Regions
2.2.1 Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Advanced Renal Cell Carcinoma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Advanced Renal Cell Carcinoma Therapeutics Industry Dynamic
2.3.1 Advanced Renal Cell Carcinoma Therapeutics Market Trends
2.3.2 Advanced Renal Cell Carcinoma Therapeutics Market Drivers
2.3.3 Advanced Renal Cell Carcinoma Therapeutics Market Challenges
2.3.4 Advanced Renal Cell Carcinoma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Advanced Renal Cell Carcinoma Therapeutics Players by Revenue
3.1.1 Global Top Advanced Renal Cell Carcinoma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Advanced Renal Cell Carcinoma Therapeutics Revenue
3.4 Global Advanced Renal Cell Carcinoma Therapeutics Market Concentration Ratio
3.4.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Renal Cell Carcinoma Therapeutics Revenue in 2020
3.5 Advanced Renal Cell Carcinoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Advanced Renal Cell Carcinoma Therapeutics Product Solution and Service
3.7 Date of Enter into Advanced Renal Cell Carcinoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Renal Cell Carcinoma Therapeutics Breakdown Data by Type
4.1 Global Advanced Renal Cell Carcinoma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2022-2027)
5 Advanced Renal Cell Carcinoma Therapeutics Breakdown Data by Application
5.1 Global Advanced Renal Cell Carcinoma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027)
6.2 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
6.2.1 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
6.3 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
6.3.1 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
6.4 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country
6.4.1 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027)
7.2 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
7.2.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
7.3.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country
7.4.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027)
9.2 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
9.2.1 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
9.3.1 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country
9.4.1 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Acceleron Pharma
11.1.1 Acceleron Pharma Company Details
11.1.2 Acceleron Pharma Business Overview
11.1.3 Acceleron Pharma Advanced Renal Cell Carcinoma Therapeutics Introduction
11.1.4 Acceleron Pharma Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.1.5 Acceleron Pharma Recent Development
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Details
11.2.2 Argos Therapeutics Business Overview
11.2.3 Argos Therapeutics Advanced Renal Cell Carcinoma Therapeutics Introduction
11.2.4 Argos Therapeutics Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.2.5 Argos Therapeutics Recent Development
11.3 AVEO Pharmaceuticals
11.3.1 AVEO Pharmaceuticals Company Details
11.3.2 AVEO Pharmaceuticals Business Overview
11.3.3 AVEO Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Introduction
11.3.4 AVEO Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.3.5 AVEO Pharmaceuticals Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Advanced Renal Cell Carcinoma Therapeutics Introduction
11.4.4 Bayer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Details
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Advanced Renal Cell Carcinoma Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.5.5 Bristol-Myers Squibb Company Recent Development
11.6 Eisai
11.6.1 Eisai Company Details
11.6.2 Eisai Business Overview
11.6.3 Eisai Advanced Renal Cell Carcinoma Therapeutics Introduction
11.6.4 Eisai Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.6.5 Eisai Recent Development
11.7 Exelixi
11.7.1 Exelixi Company Details
11.7.2 Exelixi Business Overview
11.7.3 Exelixi Advanced Renal Cell Carcinoma Therapeutics Introduction
11.7.4 Exelixi Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.7.5 Exelixi Recent Development
11.8 Genentech
11.8.1 Genentech Company Details
11.8.2 Genentech Business Overview
11.8.3 Genentech Advanced Renal Cell Carcinoma Therapeutics Introduction
11.8.4 Genentech Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.8.5 Genentech Recent Development
11.9 Immatics Biotechnologies
11.9.1 Immatics Biotechnologies Company Details
11.9.2 Immatics Biotechnologies Business Overview
11.9.3 Immatics Biotechnologies Advanced Renal Cell Carcinoma Therapeutics Introduction
11.9.4 Immatics Biotechnologies Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.9.5 Immatics Biotechnologies Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Advanced Renal Cell Carcinoma Therapeutics Introduction
11.10.4 Merck Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.10.5 Merck Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Advanced Renal Cell Carcinoma Therapeutics Introduction
11.11.4 Novartis Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.11.5 Novartis Recent Development
11.12 Ono Pharmaceutical
11.12.1 Ono Pharmaceutical Company Details
11.12.2 Ono Pharmaceutical Business Overview
11.12.3 Ono Pharmaceutical Advanced Renal Cell Carcinoma Therapeutics Introduction
11.12.4 Ono Pharmaceutical Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.12.5 Ono Pharmaceutical Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Details
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Advanced Renal Cell Carcinoma Therapeutics Introduction
11.13.4 Pfizer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.13.5 Pfizer Recent Development
11.14 Rexahn Pharmaceuticals
11.14.1 Rexahn Pharmaceuticals Company Details
11.14.2 Rexahn Pharmaceuticals Business Overview
11.14.3 Rexahn Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Introduction
11.14.4 Rexahn Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.14.5 Rexahn Pharmaceuticals Recent Development
11.15 Hoffmann-La Roche
11.15.1 Hoffmann-La Roche Company Details
11.15.2 Hoffmann-La Roche Business Overview
11.15.3 Hoffmann-La Roche Advanced Renal Cell Carcinoma Therapeutics Introduction
11.15.4 Hoffmann-La Roche Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
11.15.5 Hoffmann-La Roche Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radiation Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Hormone Therapy
Table 5. Key Players of Investigational Therapy
Table 6. Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions (2022-2027)
Table 12. Advanced Renal Cell Carcinoma Therapeutics Market Trends
Table 13. Advanced Renal Cell Carcinoma Therapeutics Market Drivers
Table 14. Advanced Renal Cell Carcinoma Therapeutics Market Challenges
Table 15. Advanced Renal Cell Carcinoma Therapeutics Market Restraints
Table 16. Global Advanced Renal Cell Carcinoma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Advanced Renal Cell Carcinoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Advanced Renal Cell Carcinoma Therapeutics as of 2020)
Table 19. Ranking of Global Top Advanced Renal Cell Carcinoma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Advanced Renal Cell Carcinoma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Advanced Renal Cell Carcinoma Therapeutics Product Solution and Service
Table 23. Date of Enter into Advanced Renal Cell Carcinoma Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Acceleron Pharma Company Details
Table 64. Acceleron Pharma Business Overview
Table 65. Acceleron Pharma Advanced Renal Cell Carcinoma Therapeutics Product
Table 66. Acceleron Pharma Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Acceleron Pharma Recent Development
Table 68. Argos Therapeutics Company Details
Table 69. Argos Therapeutics Business Overview
Table 70. Argos Therapeutics Advanced Renal Cell Carcinoma Therapeutics Product
Table 71. Argos Therapeutics Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Argos Therapeutics Recent Development
Table 73. AVEO Pharmaceuticals Company Details
Table 74. AVEO Pharmaceuticals Business Overview
Table 75. AVEO Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Product
Table 76. AVEO Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 77. AVEO Pharmaceuticals Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Advanced Renal Cell Carcinoma Therapeutics Product
Table 81. Bayer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Bristol-Myers Squibb Company Company Details
Table 84. Bristol-Myers Squibb Company Business Overview
Table 85. Bristol-Myers Squibb Company Advanced Renal Cell Carcinoma Therapeutics Product
Table 86. Bristol-Myers Squibb Company Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Bristol-Myers Squibb Company Recent Development
Table 88. Eisai Company Details
Table 89. Eisai Business Overview
Table 90. Eisai Advanced Renal Cell Carcinoma Therapeutics Product
Table 91. Eisai Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Eisai Recent Development
Table 93. Exelixi Company Details
Table 94. Exelixi Business Overview
Table 95. Exelixi Advanced Renal Cell Carcinoma Therapeutics Product
Table 96. Exelixi Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Exelixi Recent Development
Table 98. Genentech Company Details
Table 99. Genentech Business Overview
Table 100. Genentech Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Genentech Recent Development
Table 102. Immatics Biotechnologies Company Details
Table 103. Immatics Biotechnologies Business Overview
Table 104. Immatics Biotechnologies Advanced Renal Cell Carcinoma Therapeutics Product
Table 105. Immatics Biotechnologies Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Immatics Biotechnologies Recent Development
Table 107. Merck Company Details
Table 108. Merck Business Overview
Table 109. Merck Advanced Renal Cell Carcinoma Therapeutics Product
Table 110. Merck Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Merck Recent Development
Table 112. Novartis Company Details
Table 113. Novartis Business Overview
Table 114. Novartis Advanced Renal Cell Carcinoma Therapeutics Product
Table 115. Novartis Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 116. Novartis Recent Development
Table 117. Ono Pharmaceutical Company Details
Table 118. Ono Pharmaceutical Business Overview
Table 119. Ono Pharmaceutical Advanced Renal Cell Carcinoma Therapeutics Product
Table 120. Ono Pharmaceutical Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 121. Ono Pharmaceutical Recent Development
Table 122. Pfizer Company Details
Table 123. Pfizer Business Overview
Table 124. Pfizer Advanced Renal Cell Carcinoma Therapeutics Product
Table 125. Pfizer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 126. Pfizer Recent Development
Table 127. Rexahn Pharmaceuticals Company Details
Table 128. Rexahn Pharmaceuticals Business Overview
Table 129. Rexahn Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Product
Table 130. Rexahn Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 131. Rexahn Pharmaceuticals Recent Development
Table 132. Hoffmann-La Roche Company Details
Table 133. Hoffmann-La Roche Business Overview
Table 134. Hoffmann-La Roche Advanced Renal Cell Carcinoma Therapeutics Product
Table 135. Hoffmann-La Roche Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million)
Table 136. Hoffmann-La Roche Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Radiation Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Hormone Therapy Features
Figure 5. Investigational Therapy Features
Figure 6. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Advanced Renal Cell Carcinoma Therapeutics Report Years Considered
Figure 12. Global Advanced Renal Cell Carcinoma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Advanced Renal Cell Carcinoma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Players in 2020
Figure 17. Global Top Advanced Renal Cell Carcinoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Advanced Renal Cell Carcinoma Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Advanced Renal Cell Carcinoma Therapeutics Revenue in 2020
Figure 19. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Advanced Renal Cell Carcinoma Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Share by Region (2016-2027)
Figure 41. China Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Acceleron Pharma Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 61. Argos Therapeutics Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 62. AVEO Pharmaceuticals Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 64. Bristol-Myers Squibb Company Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 65. Eisai Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 66. Exelixi Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 67. Genentech Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 68. Immatics Biotechnologies Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 70. Novartis Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 71. Ono Pharmaceutical Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 72. Pfizer Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 73. Rexahn Pharmaceuticals Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 74. Hoffmann-La Roche Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Market Analysis and Insights: Global Merkel Cell Carcinoma Therapeutics Market The global Merkel Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の持続的腎代替療法（CRRT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Continuous Renal Replacement Therapy Market The global Continuous Renal Replacement Therapy market size is projected to reach US$ 999.1 million by 2026, from US$ 755.5 million in 2019, at a CAGR of 4.0% during 2021-2026. With industry-standard accuracy in analysi…
- 世界の基底細胞がん治療市場規模・現状・予測（2021年-2027年） Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams…
- 世界の急性腎不全治療市場規模・現状・予測（2021年-2027年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…